writingnotebook

(Credit: jkcDesign on Shutterstock)

In A Nutshell

  • A review of 18 randomized controlled trials found that structured positive psychology practices, including gratitude journaling, optimism training, and mindfulness meditation, were linked with modest improvements in blood pressure, inflammation, and medication adherence in adults with or at risk for heart disease.
  • Short-term cardiovascular benefits were most reliably seen in programs that ran for at least eight weeks with high-frequency engagement, and hybrid programs pairing weekly sessions with brief daily micro-tasks consistently outperformed single-mode delivery.
  • Behavioral gains like staying active and taking medications tended to persist for three to six months after programs ended, but physiological improvements such as reduced blood pressure were less durable without some form of ongoing contact or booster sessions.

Keeping a gratitude journal or practicing mindfulness for a couple of months could do more for heart health than most people would expect from a mental wellness exercise. A new research review out of the University of Illinois Urbana-Champaign analyzed 18 controlled clinical trials and found evidence that structured positive psychology practices (gratitude journaling, optimism training, and mindfulness meditation) were linked with modest improvements in blood pressure, inflammation, and other cardiovascular risk markers, with the strongest signals appearing after about eight to twelve weeks of regular practice.

Heart disease remains the leading cause of death in the United States, and the standard conversation around prevention tends to center on diet, exercise, and medication. A growing body of evidence, however, points to psychological well-being (how optimistic a person is, how much positive emotion they experience) as an independent protective factor. Observational data from large studies, including the Women’s Health Initiative and the CARDIA study, have linked higher optimism and a stronger sense of life purpose to lower rates of coronary heart disease, stroke, and cardiovascular death.

What has been less clear is how to put that connection to practical use. If cultivating a more positive mindset is genuinely good for the heart, how much do people need to practice, how often, and for how long? Those are the specific questions this review, published in Cardiology Clinics, set out to answer.

What Researchers Looked At

Lead author Rosalba Hernandez, a social work professor and American Heart Association fellow, and her colleagues synthesized evidence from 18 randomized controlled trials, the gold standard of clinical research. Collectively, the studies enrolled adults who either had established cardiovascular disease (heart failure, coronary heart disease, or a recent heart attack) or were at elevated risk due to conditions like uncontrolled hypertension. Sample sizes ranged from 30 to 324 participants, with most studies enrolling between 50 and 200 people. Mean ages typically fell in the late 50s to mid-60s.

Trials were conducted across multiple countries, though the majority took place in the United States, with additional studies in Brazil, Iran, India, China, Canada, and the Netherlands. Researchers tested a range of interventions grouped under the term “positive psychological interventions,” or PPIs. These included gratitude journaling, optimism training, mindfulness-based stress reduction (a standardized meditation program commonly delivered over eight weeks), spirituality-based programs, and multicomponent approaches that combined several strategies at once. Delivery varied widely: some programs were run in weekly in-person group sessions, others were phone-based, and a growing number used digital tools such as apps, text messages, and social media platforms like WhatsApp and WeChat.

Person holding 'Grateful' sign
Positive psychology isn’t just feel-good advice: Study finds optimism training and mindfulness tied to real cardiovascular improvements. (Photo by Nathan Dumlao on Unsplash)

How Much Gratitude and Mindfulness Practice It Takes to See Heart Benefits

Across the 18 trials, the strongest short-term signals tended to appear in programs with high-frequency engagement sustained over at least eight weeks, though dosing varied considerably and direct comparisons are difficult. Short-term cardiovascular benefits, including reduced blood pressure, lower inflammatory markers, and better heart-rate variability, were most often seen in programs running eight weeks or more. Across several mindfulness or spirituality-based programs, systolic blood pressure fell by about four to eight points in some hypertension and cardiac groups. A WhatsApp-based spirituality program running twelve weeks achieved one of the larger blood pressure reductions observed across the entire dataset, cutting office systolic blood pressure by 7.6 points and central systolic blood pressure by 4.1 points. One gratitude journaling study in heart failure patients showed reductions in inflammatory biomarkers. Optimism training trials in cardiac patients produced reductions in hs-CRP, a key inflammatory marker, as well as IL-6 and fibrinogen.

For physical activity and medication adherence, the findings were similarly encouraging. PPIs delivered over eight to twelve weeks increased daily step counts by roughly 1,800 steps per day in one positive psychology plus motivational interviewing trial. Medication adherence improved across several cardiac populations. Programs that paired weekly sessions with brief daily micro-tasks, small self-directed exercises like a one-minute gratitude reflection or a short breathing prompt, outperformed single-mode delivery in producing behavioral gains.

Long-term data were harder to come by. Only six of the 18 trials followed participants beyond the immediate post-intervention period. One year-long trial, conducted among African American adults with uncontrolled hypertension, found that medication adherence stayed about six percent higher in the intervention group compared to controls even after twelve months, sustained by periodic clinic visits and scheduled phone contacts. Several other trials with follow-ups between three and nine months showed partial maintenance of behavioral gains, though physiological improvements like reduced blood pressure were less consistent once active contact stopped.

Digital and Hybrid Delivery: What the Evidence Shows

One of the more practically useful observations from the review concerns format. Programs that blended structured weekly sessions with ongoing digital prompts outperformed those relying on a single delivery mode. Digital-only and text-based programs with daily prompts required as little as one to five minutes per contact and still managed to improve psychological stress, self-efficacy, quality of life, and in some cases blood pressure and endothelial function. For higher-risk patients, more intensive multicomponent or mindfulness-based programs with greater contact frequency appeared necessary to achieve and sustain meaningful physiological change.

Authors note, however, that longer-term physiological benefits appear to require some form of continued reinforcement. Behavioral changes like staying active and taking medications tended to carry forward three to six months after programs ended without additional contact. Physical changes like reduced blood pressure and inflammation were less durable, often fading when all contact ceased. Brief booster contacts, such as a monthly check-in or a periodic app prompt, may be enough to keep physiological gains from slipping.

Researchers offer a general dosing framework based on the compiled evidence: for physiological risk markers like blood pressure and inflammation, daily micro-tasks paired with at least one structured session per week over eight to twelve weeks appears to be the most effective approach. For sustaining behavioral improvements like medication adherence, less intensive but ongoing contact for six months or more is advisable.

Blood pressure meter and heart
A growing body of evidence points to psychological well-being (how optimistic a person is, how much positive emotion they experience) as an independent protective heart factor. (New Africa/Shutterstock)

Positive Psychology for Heart Health: A Promising Area Still in Need of More Research

Despite encouraging results across multiple outcome types, the review is careful to flag important limitations. Most of the included trials enrolled relatively small numbers of participants, often in a single clinical site, and the populations were largely homogeneous, predominantly White, middle-income, and from Western countries. Roughly 72 percent of the studies took place in Western settings. Sample diversity remains a notable gap, since cardiovascular disease affects Black and Hispanic adults at disproportionately high rates. One of the few exceptions in this dataset was a year-long trial that specifically enrolled African American adults with uncontrolled hypertension.

There is also the challenge of standardization. Trials define and measure “dose” differently enough that direct comparisons across studies are difficult. Some tracked minutes per session, others tracked the proportion of assigned tasks participants actually completed, and still others reported only total weeks of the program. Few trials tracked hard cardiovascular endpoints like hospitalizations or mortality, focusing instead on intermediate markers like blood pressure and inflammation. And follow-up periods were often too short to determine how long benefits persist in real-world conditions.

On balance, the picture from this review is reasonably encouraging, if not yet definitive. Gratitude journaling, optimism exercises, and mindfulness practices are not simply feel-good habits. When practiced with enough frequency over a sufficient period, they may produce measurable physiological changes in some groups, particularly people living with, or at significant risk for, heart disease. Whether a brief daily reflection, a weekly group session, or a WhatsApp-based spirituality program, the data suggest the specific format matters less than getting the dosing right and keeping up some form of contact over time.


Disclaimer: This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional before making any changes to your health routine, medications, or care plan.


Paper Notes

Limitations

As the authors acknowledge, this review is subject to several important constraints. Most included trials enrolled small, demographically homogeneous samples, limiting how broadly the findings can be applied across different racial, ethnic, and socioeconomic groups. Approximately 72 percent of the trials took place in Western, high-income countries, and most enrolled predominantly White, middle- to upper-income participants. Intervention dosing was poorly standardized across studies, making dose-response comparisons difficult. The majority of trials focused on psychological and behavioral outcomes rather than hard cardiovascular events such as hospitalizations, heart attacks, or mortality. Follow-up periods were generally short, restricting any conclusions about whether benefits persist beyond the active intervention phase. Finally, few trials reported on the cost, scalability, or real-world integration of these programs into standard clinical care.

Funding and Disclosures

This work was informed by prior support to corresponding author Rosalba Hernandez from the National Institutes of Health under grants K01HL130712 and R01DK129594. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors report no conflicts of interest or competing disclosures.

Publication Details

Title: Positive Psychology Interventions and Cardiovascular Health: Frequency and Duration to Sustain Cardiovascular Benefits | Authors: Rosalba Hernandez, PhD, FAHA (University of Illinois Urbana-Champaign); Soonhyung Kwon, PhD, MSW, MA (University of South Florida); Alyssa M. Vela, PhD (Northwestern University Feinberg School of Medicine); Katharine S. Edwards, PhD (Stanford Medicine) | Journal: Cardiology Clinics (Article in Press) | DOI: 10.1016/j.ccl.2025.12.001 | Published: 2026 (Elsevier Inc.) | Peer Review Status: Published in a peer-reviewed clinical cardiology journal.

About StudyFinds Analysis

Called "brilliant," "fantastic," and "spot on" by scientists and researchers, our acclaimed StudyFinds Analysis articles are created using an exclusive AI-based model with complete human oversight by the StudyFinds Editorial Team. For these articles, we use an unparalleled LLM process across multiple systems to analyze entire journal papers, extract data, and create accurate, accessible content. Our writing and editing team proofreads and polishes each and every article before publishing. With recent studies showing that artificial intelligence can interpret scientific research as well as (or even better) than field experts and specialists, StudyFinds was among the earliest to adopt and test this technology before approving its widespread use on our site. We stand by our practice and continuously update our processes to ensure the very highest level of accuracy. Read our AI Policy (link below) for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

John Anderer

Associate Editor

Leave a Comment